MX2007005336A - Analgesicos. - Google Patents

Analgesicos.

Info

Publication number
MX2007005336A
MX2007005336A MX2007005336A MX2007005336A MX2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A MX 2007005336 A MX2007005336 A MX 2007005336A
Authority
MX
Mexico
Prior art keywords
analgesic
various
compound
active ingredient
acid addition
Prior art date
Application number
MX2007005336A
Other languages
English (en)
Inventor
Hiroshi Nagabukuro
Tadatoshi Hashimoto
Naoki Izumimoto
Kuniaki Kawamura
Toshikazu Komagata
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of MX2007005336A publication Critical patent/MX2007005336A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Es descrito un analgesico el cual puede ser aplicado a una amplia variedad de dolor a partir de varias causas. El analgesico comprende como un ingrediente efectivo un derivado de morfinan especifico el cual tiene un grupo heterociclico el cual contiene nitrogeno, tal como el compuesto 1: (ver formula 1).
MX2007005336A 2004-11-04 2005-11-04 Analgesicos. MX2007005336A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04
PCT/JP2005/020297 WO2006049248A1 (ja) 2004-11-04 2005-11-04 鎮痛剤

Publications (1)

Publication Number Publication Date
MX2007005336A true MX2007005336A (es) 2007-06-25

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007005336A MX2007005336A (es) 2004-11-04 2005-11-04 Analgesicos.

Country Status (13)

Country Link
US (1) US8470845B2 (es)
EP (1) EP1820505A4 (es)
JP (1) JP4706636B2 (es)
KR (1) KR101285645B1 (es)
CN (1) CN101090722B (es)
AR (1) AR053098A1 (es)
CA (1) CA2586181C (es)
HK (1) HK1115808A1 (es)
MX (1) MX2007005336A (es)
NO (1) NO20072832L (es)
PE (1) PE20060723A1 (es)
TW (1) TW200621785A (es)
WO (1) WO2006049248A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2464593T3 (es) 2005-11-09 2014-06-03 Toray Industries, Inc. Agente terapéutico o profiláctico para trastornos funcionales digestivos
JP5163127B2 (ja) * 2005-12-21 2013-03-13 東レ株式会社 鎮咳剤
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
AU2008254037B2 (en) * 2007-05-21 2013-10-17 Toray Industries, Inc. Crystalline micropowder particles
TW200904432A (en) 2007-05-21 2009-02-01 Toray Industries Manufacturing method of pharmaceutical tablet
EP2168579B1 (en) * 2007-05-21 2017-10-11 Toray Industries, Inc. Oral preparation comprising specific organic acid, and method for improvement in dissolution property and chemical stability of oral preparation
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
EP3761982A4 (en) 2018-03-08 2021-12-15 Victoria Link Ltd TREATMENT OF DEMYELINIZATION DISEASES

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (es) * 1964-02-03 1966-10-31
US3318886A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.
JP3843456B2 (ja) 1993-07-23 2006-11-08 東レ株式会社 モルヒナン誘導体および医薬用途
WO1996027375A2 (en) 1995-03-03 1996-09-12 Algos Pharmaceutical Corporation Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
EP1203771A4 (en) * 1999-07-19 2003-07-30 Toray Industries HEALING OR PREVENTIVE AGENTS FOR THE TREATMENT OF FREQUENCY OF URINATION AND CONTINUITY
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
EP1944292B9 (en) 2000-10-31 2016-07-06 Rensselaer Polytechnic Institute 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
US7320984B2 (en) 2002-10-09 2008-01-22 Toray Industries, Inc. Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
PT1736157E (pt) 2004-03-30 2008-12-31 Toray Industries Derivados de morfinano como agentes anti-prurido

Also Published As

Publication number Publication date
US8470845B2 (en) 2013-06-25
KR20070085436A (ko) 2007-08-27
JP4706636B2 (ja) 2011-06-22
EP1820505A1 (en) 2007-08-22
PE20060723A1 (es) 2006-08-29
CN101090722A (zh) 2007-12-19
EP1820505A4 (en) 2010-01-20
CN101090722B (zh) 2011-12-21
CA2586181C (en) 2012-11-27
TWI356826B (es) 2012-01-21
AR053098A1 (es) 2007-04-25
JPWO2006049248A1 (ja) 2008-08-07
TW200621785A (en) 2006-07-01
NO20072832L (no) 2007-08-01
WO2006049248A1 (ja) 2006-05-11
US20070299100A1 (en) 2007-12-27
KR101285645B1 (ko) 2013-07-12
HK1115808A1 (en) 2008-12-12
CA2586181A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
MX2007005336A (es) Analgesicos.
MY147211A (en) Novel dihydropseudoerythromycin derivatives
WO2008143240A1 (ja) 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
TW200615266A (en) Organic compounds
TNSN08407A1 (en) Organic compounds
WO2009060835A8 (ja) 新規ユビキリン結合性小分子
TW200714583A (en) Substituted gamma lactams as therapeutic agents
TW200728307A (en) Novel spirochromanone derivatives
TW200744588A (en) Pharmaceutical composition for external use
PT1379520E (pt) Antagonistas (nao-aril)-heterociclicos n-substituidos de nmda/nr2b
RS20050462A (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
BRPI0507617A (pt) antagonistas de receptor de quimiocina
TW200626558A (en) Indazolone derivatives
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
WO2005092304A3 (en) Antifungal agents
MX2009013730A (es) Compuesto amina y uso farmaceutico del mismo.
WO2007005941A3 (en) Liver targeted conjugates
MX2009001578A (es) Lactamas terapeuticas.
WO2008093838A1 (ja) スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用
WO2007146856A3 (en) Substituted gamma lactams as therapeutic agents
WO2008139845A1 (ja) 新規アミド誘導体
GB0212410D0 (en) Organic compounds
EP1219296A4 (en) SEBUM PRODUCTION INHIBITORS

Legal Events

Date Code Title Description
FG Grant or registration